Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis

PURPOSE: To extend a prior real-world analysis (DARWIN-T2D) of patients with type 2 diabetes initiating dapagliflozin in Italy, Greece, and Spain by evaluating changes in glycemic and extra-glycemic endpoints after initiation of dapagliflozin. PATIENTS AND METHODS: The association among demographic/...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadini, Gian Paolo, Morales, Cristobal, Caballero, Irene, González, Beatriz, Tentolouris, Nikolaos, Consoli, Agostino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675331/
https://www.ncbi.nlm.nih.gov/pubmed/36411790
http://dx.doi.org/10.2147/DMSO.S390075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675331/
https://www.ncbi.nlm.nih.gov/pubmed/36411790
http://dx.doi.org/10.2147/DMSO.S390075

Ejemplares similares